Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Minor

Showing results (51-60 of 191) with videos related to

Pageof 20
Sort By:
The Journal of General Virology|November 1, 1986
Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptidesM Ferguson, S E Reed, P D Minor
Biologicals : Journal of the International Association of Biological Standardization|July 1, 1991
The 1st International Standard for anti-measles serumT Forsey, A B Heath, P D Minor
Vaccine|October 12, 2000
Vaccines and variant CJDP D Minor, R G Will, D Salisbury
Biologicals : Journal of the International Association of Biological Standardization|September 1, 1993
A European collaborative study to assess the proficiency of laboratory estimates of potency of live measles, mumps and rubella tri-valent vaccinesT Forsey, A B Heath, P D Minor
The Journal of General Virology|April 1, 1993
Antigenic structure of poliovirus in inactivated vaccinesM Ferguson, D J Wood, P D Minor
The Journal of General Virology|February 1, 1991
Comparison of the nucleotide sequence of the SH gene and flanking regions of mumps vaccine virus (Urabe strain) grown on different substrates and isolated from vaccineesP C Turner, T Forsey, P D Minor
Vaccine|May 12, 2001
Detection and growth kinetics of SV40 preparations with different enhancer element copy numberP D Minor, G Dunn, P A Pipkin
Nature|September 9, 1982
Poliomyelitis--epidemiology, molecular biology and immunologyP D Minor, O Kew, G C Schild
Vox Sanguinis|April 26, 2007
Reference materials for the evaluation of pre-mortem variant Creutzfeldt-Jakob disease diagnostic assaysJ K Cooper, K Ladhani, P D Minor
Bulletin of the World Health Organization|April 1, 2000
Clinical safety issues of measles, mumps and rubella vaccinesM A Afzal, P D Minor, G C Schild
Pageof 20

Showing results (51-60 of 191) with videos related to

Sort By:
Pageof 20
The Journal of General Virology|November 1, 1986
Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptidesM Ferguson, S E Reed, P D Minor
Biologicals : Journal of the International Association of Biological Standardization|July 1, 1991
The 1st International Standard for anti-measles serumT Forsey, A B Heath, P D Minor
Vaccine|October 12, 2000
Vaccines and variant CJDP D Minor, R G Will, D Salisbury
Biologicals : Journal of the International Association of Biological Standardization|September 1, 1993
A European collaborative study to assess the proficiency of laboratory estimates of potency of live measles, mumps and rubella tri-valent vaccinesT Forsey, A B Heath, P D Minor
The Journal of General Virology|April 1, 1993
Antigenic structure of poliovirus in inactivated vaccinesM Ferguson, D J Wood, P D Minor
The Journal of General Virology|February 1, 1991
Comparison of the nucleotide sequence of the SH gene and flanking regions of mumps vaccine virus (Urabe strain) grown on different substrates and isolated from vaccineesP C Turner, T Forsey, P D Minor
Vaccine|May 12, 2001
Detection and growth kinetics of SV40 preparations with different enhancer element copy numberP D Minor, G Dunn, P A Pipkin
Nature|September 9, 1982
Poliomyelitis--epidemiology, molecular biology and immunologyP D Minor, O Kew, G C Schild
Vox Sanguinis|April 26, 2007
Reference materials for the evaluation of pre-mortem variant Creutzfeldt-Jakob disease diagnostic assaysJ K Cooper, K Ladhani, P D Minor
Bulletin of the World Health Organization|April 1, 2000
Clinical safety issues of measles, mumps and rubella vaccinesM A Afzal, P D Minor, G C Schild
Pageof 20